About Södra Älvsborgs Sjukhus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Karolinska Institutet
3
Sahlgrenska University Hospital, Sweden
3
German CLL Study Group
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
Uppsala University
2
Vastra Gotaland Region
2
Amgen
1
Anders Svenningsson
1
Annika Bergquist
1
Bayer
1
BeiGene
1
Clinical Trials at Södra Älvsborgs Sjukhus
During the past decade, Södra Älvsborgs Sjukhus conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 1 clinical trials were completed, i.e. on
average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes
2005-01-01
2007-12-01
Completed
70
Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse
2007-12-01
2010-01-01
Completed
400
Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
2011-01-01
2023-04-01
Unknown status
1,503
Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial
2011-06-21
2026-12-31
Active, not recruiting
920
Hospital- and Home-based Supervised Exercise Versus UNsupervised Walk Advice For Patients With InTermittent Claudication
2014-09-01
2022-06-01
Active, not recruiting
165
RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.
2016-05-01
2021-08-01
Completed
200
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
2016-12-13
2024-01-31
Active, not recruiting
926
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Södra Älvsborgs Sjukhus" #1 sponsor was "Karolinska Institutet" with 3 trials, followed by "Sahlgrenska University Hospital, Sweden" with 3 trials
sponsored, "German CLL Study Group" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored and "Uppsala University"
with 2 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Södra Älvsborgs Sjukhus"
#1 collaborator was "Karolinska University Hospital" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator and "The Swedish Research Council" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were
collaborators in the rest 48 trials.
Clinical Trials Conditions at Södra Älvsborgs Sjukhus
According to Clinical.Site data, the most researched conditions in "Södra Älvsborgs Sjukhus" are
"Chronic Lymphocytic Leukemia" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Myocardial Infarction" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Acute Vestibular Syndrome" (1 trials). Many other conditions were trialed in "Södra Älvsborgs Sjukhus" in a lesser frequency.
Clinical Trials Intervention Types at Södra Älvsborgs Sjukhus
Most popular intervention types in "Södra Älvsborgs Sjukhus" are "Drug" (14 trials), "Procedure" (5 trials), "Other" (4 trials), "Biological" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.
The name of intervention was led by "Ibrutinib" (3 trials), "Rituximab" (3 trials), "Obinutuzumab" (2 trials), "Placebo" (2 trials) and "Venetoclax" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Södra Älvsborgs Sjukhus
The vast majority of trials in "Södra Älvsborgs Sjukhus" are
25 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Södra Älvsborgs Sjukhus
Currently, there are NaN active trials in "Södra Älvsborgs Sjukhus".
undefined are not yet recruiting,
10 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Södra Älvsborgs Sjukhus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Södra Älvsborgs Sjukhus, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 10 trials that are defined as “Not Applicable".